Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Jul 19;327(7407):150-3.
doi: 10.1136/bmj.327.7407.150.

New developments in percutaneous coronary intervention

Julian Gunn  1 , David Crossman, Ever D Grech, David Cumberland
Affiliations
Review

New developments in percutaneous coronary intervention

Julian Gunn et al. BMJ. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Triple vessel disease is no longer a surgical preserve, and particularly good results are expected with drug eluting stents. In this case, lesions in the left anterior descending (LAD), circumflex (Cx), and right coronary arteries (RCA) (top row) are treated easily and rapidly by stent (S) implantation (bottom row)
Figure 2
Figure 2
Unprotected left main stem stenoses (LMS, top) may, with careful selection, be treated by stent implantation (S, bottom). Best results (similar to coronary artery bypass surgery) are achieved in stable patients with good left ventricular function and no other disease. Close follow up to detect restenosis is important. (LAD=left anterior descending artery, Cx=circumflex coronary artery)
Figure 2
Figure 2
Unprotected left main stem stenoses (LMS, top) may, with careful selection, be treated by stent implantation (S, bottom). Best results (similar to coronary artery bypass surgery) are achieved in stable patients with good left ventricular function and no other disease. Close follow up to detect restenosis is important. (LAD=left anterior descending artery, Cx=circumflex coronary artery)
Figure 4
Figure 4
Angiograms showing severe, diffuse, in-stent restenosis in the left anterior descending artery and its diagonal branch (L and D, left). This was treated with balloon dilatation and brachytherapy with β irradiation (Novoste) from a catheter (Br, centre), with an excellent final result (right)
Figure 5
Figure 5
Angiogram of an aortocoronary vein graft with an aneurysm and stenoses (A and S, top). Treatment by implantation of a membrane-covered stent excluded the aneurysm and restored a tubular lumen (bottom)
Figure 5
Figure 5
Angiogram of an aortocoronary vein graft with an aneurysm and stenoses (A and S, top). Treatment by implantation of a membrane-covered stent excluded the aneurysm and restored a tubular lumen (bottom)
Figure 7
Figure 7
Bifurcation lesions, such as of the left anterior descending artery and its diagonal branch (L and D, left), are technically challenging to treat but can be well dilated by balloon dilatation and selective stenting (S, right)
Figure 8
Figure 8
An acute coronary syndrome was found to be due to stenoses and an ulcerated plaque in the right coronary artery (S and U, left). This was treated with a glycoprotein IIb/IIIa inhibitor followed by stent implantation (right). This is an increasingly common presentation of coronary artery disease to catheterisation laboratories
Figure 8
Figure 8
An acute coronary syndrome was found to be due to stenoses and an ulcerated plaque in the right coronary artery (S and U, left). This was treated with a glycoprotein IIb/IIIa inhibitor followed by stent implantation (right). This is an increasingly common presentation of coronary artery disease to catheterisation laboratories
Figure 10
Figure 10
Right coronary artery containing large, lobulated thrombus (T, left) on a substantial stenosis. After treatment with glycoprotein IIb/IIIa inhibitor, the lesion was stented successfully (St, right)
See this image and copyright information in PMC

References

    1. Morice M-C, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346: 1773-80 - PubMed
    1. Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK, et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003;348: 1537-45 - PubMed
    1. Raco DL, Yusuf S. Overview of randomised trials of percutaneous coronary intervention: comparison with medical and surgical therapy for chronic coronary artery disease. In: Grech ED, Ramsdale DR, eds. Practical interventional cardiology. 2nd ed. London: Martin Dunitz, 2002: 263-77
    1. Teirstein PS, Kuntz RE. New frontiers in interventional cardiology: intravascular radiation to prevent restenosis. Circulation 2001;104: 2620-6 - PubMed
    1. Tsuji T, Tamai H, Igaki K, Kyo E, Kosuga K, Hata T, et al. Biodegradable stents as a platform to drug loading. Int J Cardiovasc Intervent 2003;5: 13-6 - PubMed

MeSH terms